Protocol summary

Study aim
Determining the effect of inhibiting visual and auditory stimuli during night sleep on the amount of analgesic medication required during waking hours in patients admitted to the Intensive Care Unit of burn.
Design
Clinical trial, parallel groups, double-blind, randomized, phase 3 on 30 patients. In order to randomize, the block randomization method will be used. In order to randomize, a random number table will be used.
Settings and conduct
In this research, all patients hospitalized in the Intensive Care Unit of burn, with sleep disorders, in Shahid Motahari Hospital, Tehran, will be included in the study. Patients will be randomly divided into 2 groups based on blocks of 6. The sample size for each study group is 15 people. A total of 30 patients will be examined. Data collection and data analysis will be blinded.
Participants/Inclusion and exclusion criteria
Burn percentage between 30 and 60%, consciousness, Age between 15-55 years Having a sleep disorder The minimum stay of the patient in the intensive care unit is expected to be eight days and nights Vision or hearing impairment, history of addiction, mental disorder, sleep apnea, head and face burns, phobia of the dark
Intervention groups
Intervention group: During the 48 hours of examining the patients, during night sleep from 22:00 to 6:00, light and sound stimuli will be controlled with the help of ear muffs and blindfolds. Control group: During the 48 hours of examination, the patients will sleep at night without the control of sound and light stimuli, from 22:00 to 6:00. The next day, the amount of prescribed narcotics and non-opioid painkillers, the intensity of the patient's pain from 0: no pain to 10: the most severe pain he has ever experienced will be recorded.
Main outcome variables
Pain

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20230506058100N3
Registration date: 2024-07-14, 1403/04/24
Registration timing: prospective

Last update: 2024-07-14, 1403/04/24
Update count: 0
Registration date
2024-07-14, 1403/04/24
Registrant information
Name
Tahereh Chavoshi
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 21 2304 6253
Email address
chavoshi.t@iums.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2024-07-22, 1403/05/01
Expected recruitment end date
2025-01-20, 1403/11/01
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Determining the effect of inhibiting visual and auditory stimuli during night sleep on the amount of analgesic medication required
Public title
Determining the effect of inhibiting visual and auditory stimuli during night sleep
Purpose
Supportive
Inclusion/Exclusion criteria
Inclusion criteria:
Age between 15-55 years Burn percentage between 30 and 60 consciousness Having a sleep disorder The minimum stay of the patient in the Intensive Care Unit is expected to be eight days and nights
Exclusion criteria:
Vision or hearing impairment History of addiction Mental disorder Sleep apnea Head and face burns Phobia of the dark
Age
From 15 years old to 55 years old
Gender
Both
Phase
3
Groups that have been masked
  • Investigator
  • Outcome assessor
Sample size
Target sample size: 30
Randomization (investigator's opinion)
Randomized
Randomization description
Patients will be randomly divided into 2 groups. The randomization tool will randomize the table of numbers. Block randomization method will be used for randomization. Block randomization is for the purpose of making sure that exactly equal number of participants enter the study groups. The advantages of block randomization are that the balance of the number of participants in each group is guaranteed. For this purpose, 6 blocks will be formed and in each block 3 people from intervention group and 3 people will be placed in the control group. A total of 5 blocks will be considered to reach the sample size. Blocks contain numbers, numbers represent study groups. Their order will be determined by the statistician from the beginning. In order to hide the random allocation, opaque envelopes sealed with a random sequence will be used. In this method, each of the generated random sequences will be recorded on a card and the cards will be placed in the envelopes in order. became. In order to maintain a random sequence, the outer surface of the envelopes is numbered in the same order. Finally, the lid of the letter envelopes is glued and placed in a box. At the time of registration of participants, based on the order of entry of qualified participants into the study, one of the envelopes will be opened in order and the assigned group of that participant will be revealed.
Blinding (investigator's opinion)
Single blinded
Blinding description
Patients will be aware that they will be randomly assigned to one of the two study groups, and they will also be aware of the group they will be placed in. The person in charge of data collection, the analyst and the outcome evaluator will collect and analyze the information based on groups 1 and 2 and will not know the type of drug injected in the groups and will be kept blind.
Placebo
Not used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics committee of Iran University of Medical Sciences
Street address
Iran University of Medical Sciences, Hemmat Highway
City
Tehran
Province
Tehran
Postal code
1449614535
Approval date
2024-05-07, 1403/02/18
Ethics committee reference number
IR.IUMS.FMD.REC.1403.067

Health conditions studied

1

Description of health condition studied
burn
ICD-10 code
T29.0
ICD-10 code description
Burns of multiple regions, unspecified degree

Primary outcomes

1

Description
Pain
Timepoint
6 am, after a night's sleep, for 48 hours
Method of measurement
Numeric scale

Secondary outcomes

empty

Intervention groups

1

Description
Intervention group: During the 48 hours of examining the patients, during night sleep from 22:00 to 6:00, light and sound stimuli will be controlled with the help of ear muffs and blindfolds, and the next day, the amount of prescribed narcotics and non-opioid painkillers, intensity The patient's pain will be recorded from 0: no pain to 10: the most severe pain he has ever experienced.= The worst pain ever experienced will be recorded.
Category
Treatment - Devices

2

Description
Control group: During the 48 hours of examination, the patients will sleep at night without the control of sound and light stimuli, from 22:00 to 6:00. The next day, the amount of prescribed narcotics and non-opioid painkillers, the intensity of the patient's pain from 0: no pain to 10: the most severe pain he has ever experienced will be recorded.
Category
Treatment - Devices

Recruitment centers

1

Recruitment center
Name of recruitment center
Shahid Motahari Hospital
Full name of responsible person
Ebrahim Eskandari
Street address
Rashid Yasmi St, above Mirdamad St, Valiasr St.
City
Tehran
Province
Tehran
Postal code
1996714353
Phone
+98 21 8877 0036
Email
motahari.hos@iums.ac.ir

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Saeed Aghajani
Street address
Iran University of Medical Sciences, Hemmat Highway, Tehran
City
Tehran
Province
Tehran
Postal code
1449614535
Phone
+98 21 8670 2503
Email
research@iums.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Iran University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Ebrahim Eskandari
Position
Resident
Latest degree
Medical doctor
Other areas of specialty/work
Anesthesiology
Street address
Rasool Akram Hospital, Maziar Mansouri Street, Sattar Khan Street
City
Tehran
Province
Tehran
Postal code
1445613131
Phone
+98 21 6435 2222
Email
dreskandari2016@gmail.com

Person responsible for scientific inquiries

Contact
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Reza Salehi
Position
Assistant Professor
Latest degree
Specialist
Other areas of specialty/work
Anesthesiology
Street address
Hazrat Ali Asghar Hospital street, Shahid Vahid Dastgardi, Modares highway (north)
City
Tehran
Province
Tehran
Postal code
1919816766
Phone
+98 21 2222 2042
Email
rsalehi45@yahoo.com

Person responsible for updating data

Contact
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Ebrahim Eskandari
Position
Resident
Latest degree
Medical doctor
Other areas of specialty/work
Anesthesiology
Street address
Rasool Akram Hospital, Maziar Mansouri Street, Sattar Khan Street
City
Tehran
Province
Tehran
Postal code
1445613131
Phone
+98 21 6435 2222
Email
dreskandari2016@gmail.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available
Loading...